J 2014

Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency

POSPÍŠILOVÁ, Dagmar, D. HOLUB, Z. ZIDOVA, L. SULOVSKA, J. HOUDA et. al.

Basic information

Original name

Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency

Authors

POSPÍŠILOVÁ, Dagmar (203 Czech Republic), D. HOLUB (203 Czech Republic), Z. ZIDOVA (203 Czech Republic), L. SULOVSKA (203 Czech Republic), J. HOUDA (203 Czech Republic), V. MIHAL (203 Czech Republic), I. HADACOVA (203 Czech Republic), Lenka RADOVÁ (203 Czech Republic, guarantor, belonging to the institution), P. DZUBAK (203 Czech Republic), Marian HAJDÚCH (203 Czech Republic), Vladimír DIVOKÝ (203 Czech Republic) and M. HORVATHOVA (203 Czech Republic)

Edition

Haematologica, PAVIA, FERRATA STORTI FOUNDATION, 2014, 0390-6078

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Italy

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.814

RIV identification code

RIV/00216224:14740/14:00078458

Organization unit

Central European Institute of Technology

UT WoS

000342833500008

Keywords in English

Diamond Blackfan anemia; hepcidin levels; erythropoietic activity; transfusion dependency

Tags

International impact, Reviewed
Změněno: 6/3/2015 09:04, Martina Prášilová

Abstract

V originále

Diamond-Blackfan anemia (DBA) is a rare congenital red cell aplasia associated with mutations in ribosomal proteins (RP) in 49-71% of cases.1 DBA is a clinically heterogeneous disorder with one-third of patients developing transfusion-acquired iron overload.2 The severity of anemia and transfusion dependency in DBA is comparable to transfusiondependent beta-thalassemia major; however, moderate to severe suppression of erythropoiesis in DBA2 is in contrast to accelerated ineffective erythropoiesis in beta-thalassemia.3,4 The knowledge of systemic iron regulation in DBA is limited.

Links

306242, interní kód MU
Name: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: European Union, Cooperation